doi:10.1007/s12250-009-2983-x

[1]
Hai-Yan Yan, Hui-Qiang Wang, Ming Zhong, Shuo Wu, Lu Yang, Ke Li, Yu-Huan Li, 2021: PML Suppresses Influenza Virus Replication by Promoting FBXW7 Expression, Virologica Sinica, 36, 1154-1164. doi: 10.1007/s12250-021-00399-3
[2]
Mengwei Li, Yuxu Wang, Jing Jin, Jie Dou, Qinglong Guo, Xue Ke, Changlin Zhou, Min Guo, 2021: Inhibitory Activity of Honeysuckle Extracts against Influenza A Virus In Vitro and In Vivo, Virologica Sinica, 36, 490-500. doi: 10.1007/s12250-020-00302-6
[3]
Ruikun Du, Qinghua Cui, Zinuo Chen, Xiujuan Zhao, Xiaojing Lin, Lijun Rong, 2023: Revisiting influenza A virus life cycle from a perspective of genome balance, Virologica Sinica, 38, 1-8. doi: 10.1016/j.virs.2022.10.005
[4]
Shijuan Gao, Jiandong Li, Liping Song, Jiaoxiang Wu, Wenlin Huang, 2017: Influenza A virus-induced downregulation of miR-26a contributes to reduced IFNα/β production, Virologica Sinica, 32, 261-270. doi: 10.1007/s12250-017-4004-9
[5]
Wenling Wang, Baoying Huang, Xiuping Wang, Wenjie Tan, Li Ruan, 2019: Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats, Virologica Sinica, 34, 583-591. doi: 10.1007/s12250-019-00138-9
[6]
Jian Chen, Jian Liu, Zhilu Chen, Daobin Feng, Cuisong Zhu, Jun Fan, Shuye Zhang, Xiaoyan Zhang, Jianqing Xu, 2023: Nonmuscle myosin IIA promotes the internalization of influenza A virus and regulates viral polymerase activity through interacting with nucleoprotein in human pulmonary cells, Virologica Sinica, 38, 128-141. doi: 10.1016/j.virs.2022.12.002
[7]
Xiwen Zhao, Xuan Dai, Fuyi Wang, Chenyang Li, Xun Song, Yingying Han, Chaowei Zhang, Lu Wang, Zhendan He, Rongping Zhang, Liang Ye, 2025: Artemisia annua L. leaf extracts suppress influenza virus infection by targeting the viral nucleoprotein and blocking mitochondria-mediated apoptosis, Virologica Sinica, 40, 247-259. doi: 10.1016/j.virs.2025.03.001
[8]
Jiajie Wei, Jonathan W. Yewdell, 2019: Flu DRiPs in MHC Class Ⅰ Immunosurveillance, Virologica Sinica, 34, 162-167. doi: 10.1007/s12250-018-0061-y
[9]
Meiyue Dong, Yanyan Wang, Ping Li, Zinuo Chen, Varada Anirudhan, Qinghua Cui, Lijun Rong, Ruikun Du, 2023: Allopregnanolone targets nucleoprotein as a novel influenza virus inhibitor, Virologica Sinica, 38, 931-939. doi: 10.1016/j.virs.2023.09.003
[10]
Shuoxuan Zhao, Yichao Chen, Tianxin Zhang, Yaoyao Gao, Jing Wu, Fangji Yang, Yongxiang Liu, Xuesong Liu, Nan Qi, 2026: Degradation of ACSL3 by influenza A virus shifts unfolded protein response from antiviral defense to viral evasion, Virologica Sinica, 41, 638-650. doi: 10.1016/j.virs.2026.06.008
[11]
Yuhan Gong, Junwen Liu, Wenxuan Ding, Yuxing Yan, Xue Hu, Gary Wong, Huaijie Jia, Zhengxiang Wang, Xin Li, Jiayi Chen, Xin Zhang, Chao Shan, Shuai Xu, Xiaoxia Wang, 2026: Antiviral activity of Saponin C from Liriope muscari against influenza A virus and SARS-CoV-2, Virologica Sinica, 41, 662-675. doi: 10.1016/j.virs.2026.06.002
[12]
Yingying Yu, Qian Wang, Yanli Wei, Junwen Liu, Guangwen Wang, Zhengxiang Wang, Wentao Shen, Lu Han, Chengjun Li, Cao-Qi Lei, Shuai Xu, Qiyun Zhu, 2025: Nucleophosmin 1 inhibits the replication of influenza A virus by competitively binding viral RNA with viral proteins, Virologica Sinica, 40, 388-400. doi: 10.1016/j.virs.2025.04.007
[13]
严银芳, 陈晓, 杨小清, 吴少华, 方冬芬, 董长垣, 2002: The Cooperative Anti-influenza Virus Activities of Amantadine， Ribavirin and Herby Houttuynia, Virologica Sinica, 17, 192-194.
[14]
Mingkun Wu, Liru Guo, Mei Kong, Ming Zou, Xiaochang Liu, Xiaoyan Li, 2025: Epidemiological and genomic surveillance of influenza A virus (pdm09 H1N1 and H3N2) strains from 2017 to 2025 in Tianjin, China, Virologica Sinica, 40, 535-545. doi: 10.1016/j.virs.2025.07.011
[15]
Xianmiao Ye, Junnan Lu, Zirong Han, Zhishan Fan, Xinru Hu, Lichuang Jiao, Lisha Deng, Wenming Liu, Junqi Liu, Weiqi Pan, Ling Chen, Liqiang Feng, Caijun Sun, 2026: A semi-replicating VSV (srVSV)-based platform for developing broad-spectrum mucosal vaccines against influenza A viruses, Virologica Sinica, 41, 423-438. doi: 10.1016/j.virs.2026.04.004
[16]
Liping Ma, Huabin Zheng, Xianliang Ke, Rui Gui, Zhongzi Yao, Jiasong Xiong, Quanjiao Chen, 2024: Mutual antagonism of mouse-adaptation mutations in HA and PA proteins on H9N2 virus replication, Virologica Sinica, 39, 56-70. doi: 10.1016/j.virs.2023.11.004
[17]
杨占秋, 朱宝莲, 张美英, 1987: INHIBITORY EFFECTS OF RIBAVIRIN AGAINST EPIDEMIC HEMORRHAGIC FEVER VIRUS IN CELL CULTURE, Virologica Sinica, 2, 104-.
[18]
Yan SUN, Li-jun LI, Jing LI, Zhi LI, 2007: Inhibition of Hepatitis B Virus Replication by Rheum palmatum L. Ethanol Extract in a Stable HBV-producing Cell Line, Virologica Sinica, 22, 14-20.
[19]
Cheng Peng, Jialing Hu, Yuan Bai, Wei Wu, Wenting Mao, Yang Liu, Yi Wan, Lei Zhang, Wei Li, Tingting Tian, Tiezhu Liu, Yanhai Wang, Mifang Liang, Jun Han, Zhiming Yuan, Jiandong Li, Chao Shan, Fei Deng, Wei Wang, 2025: Coadministration of ribavirin and arenaviral entry inhibitor LHF-535 enhances antiviral benefit against authentic lassa virus, Virologica Sinica, 40, 491-494. doi: 10.1016/j.virs.2025.04.003
[20]
黄华芳, 熊开钧, 何生松, 李瑗, 王萍, 蔡淑清, 曾令兰, 王心禾, 1991: The Observation on the Antiviral Effect of Ribavirin and Combining with Interferon in Patients with Chronic Hepatitis B, Virologica Sinica, 6, 201-.